Showing results (1-10 of 560) with videos related to
Sort By:
Pageof 56
Current Opinion in Oncology|June 10, 2004
Monoclonal antibodies against vascular endothelial growth factor and epidermal growth factor receptor in advanced colorectal cancers: present and future directionsNaureen Starling, David CunninghamBritish Journal of Cancer|February 16, 2023
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer: S Pyrhönen, T Kuitunen, P Nyandoto & M KouriNaureen Starling, David CunninghamCurrent Oncology Reports|April 26, 2005
Second-line therapy for advanced colorectal carcinomaNaureen Starling, David CunninghamClinical Colorectal Cancer|May 6, 2005
Cetuximab in previously treated colorectal cancerNaureen Starling, David CunninghamTherapeutics and Clinical Risk Management|March 25, 2008
Role of erlotinib in the management of pancreatic cancerNaureen Starling, John Neoptolemos, David CunninghamCancer Treatment Reviews|July 3, 2024
HER-2 directed therapies across gastrointestinal tract cancers - A new frontierLauren Jones, David Cunningham, Naureen StarlingExpert Opinion on Pharmacotherapy|August 5, 2016
Targeting deficient DNA damage repair in gastric cancerKate Young, Naureen Starling, David CunninghamGastroenterology Research and Practice|January 14, 2020
Contemporary Tailored Oncology Treatment of Biliary Tract CancersFiona Turkes, Juliet Carmichael, David Cunningham, et al.Critical Reviews in Oncology/Hematology|April 30, 2015
Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targetsFrancesco Sclafani, Ridhima Iyer, David Cunningham, et al.Therapeutic Advances in Medical Oncology|July 24, 2018
The evolving immunotherapeutic landscape in advanced oesophagogastric cancerMichael Flynn, Kate Young, David Cunningham, et al.Pageof 56